Navigation Links
Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting

BIRMINGHAM, Ala., April 03, 2007 /PRNewswire/ -- Southern Research Institute, a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and drug development today announced that its scientists will be delivering one oral presentation and 10 poster presentations at the 2007 American Association for Cancer Research (AACR) Annual Meeting, April 14-18 in Los Angeles, Calif.

Anshu Mittal Roy of Southern Research will be presenting new data on the different factors that contribute to tumor growth. The discussion titled "VEGF Overexpression Increases Stromal Content in Both Primary Tumor and Metastatic Lesions" will be presented on Tuesday, April 17, from 11:25 a.m. - 11:40 a.m. in Room 404 A-B, Los Angeles Convention Center.

Scientists from Southern Research will also present preclinical data in posters at the Exhibit Hall:

    Sunday, April 15

     -- Jose T. Thaiparambil will be presenting poster (#644) "Sulindac

        Sulfide Selectively Inhibits cGMP PDE from Human HT-29 Colon Tumor

        Cells" from 8:00 a.m. -12:00 p.m.


     -- Patricia E. Noker will be presenting poster (#1545) "Toxicity and

        Pharmacokinetics of 1-Methyl-D-Tryptophan in Rats and Dogs" from 1:00

        p.m. - 5:00 p.m.


    Monday, April 16

     -- Rongbao Li will be presenting poster (#3165) "Structural Basis for

        PYK2 Adhesion Targeting" from 1:00 p.m. - 5:00 p.m.


     -- Adam B. Keeton will be presenting poster (#2282) "Reversal of MRP-1

        Mediated Multi-Drug Resistance by Sulinda Sulfide and Indomethacin"

        from 8:00 a.m. - 12:00 p.m.


    Tuesday, April 17

     -- Bo Xu will be presenting poster (#3895) "Regulation of ATM

        Phosphorylation in the Absence of DNA Damage" from 8:00 a.m. - 12:00

        p.m.


     -- Mickael J. Cariveau will be presenting poster (#3893) "Interfering

        with NBS1-ATM Interaction to Inhibit the DNA Damage Response and

     
   Sensitize Tumor Cells to Radiation" from 8:00 a.m. - 12:00 p.m.


     -- Jaideep V. Thottassery will be presenting poster (#4375) "Cks1

        Regulates Cdk1 Expression: A novel Role during Mitotic Entry in Breast

        Cancer Cells" from 1:00 p.m. - 5:00 p.m.


     -- Yonghe Li will be presenting poster (#4385) "Opposing Roles of Dkk1 in

        LRP6 Stabilization and Wnt Signaling: Implication for Wnt Ligand-

        induced LRP6 Down-regulation" from 1:00 p.m. - 5:00 p.m.


     -- Zhican Qu will be presenting poster (#8935) "Screening for Specific

        Anti-angiogenic Agents" from 1:00 p.m. - 5:00 p.m.


    Wednesday, April 18

     -- Bo Xu will be presenting poster (#5055) "Clofarabine Acts

        Synergistically with Ionizing Radiation In Vitro and In Vivo by

        Inhibiting the Repair of DNA Damage" from 8:00 a.m. - 12:00 p.m.

To date, Southern Research has discovered six of the FDA-approved anti- cancer drugs and four additional drugs that are currently in clinical trials. Further, Southern Research has evaluated almost 70% of all other FDA-approved cancer drugs on the market. Seventy-five percent of all FDA approved HIV drugs have also been evaluated at Southern Research during development.

ABOUT SOUTHERN RESEARCH

Southern Research is a not-for-profit organization that conducts scientific research at facilities in Alabama, Florida, Maryland and North Carolina. Southern Research provides contract research in the fields of preclinical drug discovery and development, advanced engineering, environmental and energy-related research. For more information, see www.SouthernResearch.org.

    Media Contacts:


    Rhonda Jung                      Risa Burgess

    205-581-2317                     781-684-0770

    Southern Research Institute      Schwartz Communications, Inc.

            

Jung@SouthernResearch.org Southern@schwartz-pr.com

CONTACT: Rhonda Jung of Southern Research, +1-205-581-2317,; or Risa Burgess for Southern Research,+1-781-684-0770, Jung@SouthernResearch.org Southern@schwartz-pr.com

Web site: http://www.southernresearch.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
8. President Bush Ignores Americas Plea for Support of Stem Cell Research
9. Researchers Discover Gene For Rare Skin Disorder
10. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
11. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):